# Vaginal Microbiota Transplant

> **NCT04046900** · PHASE1,PHASE2 · RECRUITING · sponsor: **Douglas Kwon** · enrollment: 62 (estimated)

## Conditions studied

- Recurrent Bacterial Vaginosis

## Interventions

- **BIOLOGICAL:** Vaginal microbiome transplant
- **DRUG:** Oral Metronidazole
- **OTHER:** Sterile saline

## Key facts

- **NCT ID:** NCT04046900
- **Lead sponsor:** Douglas Kwon
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-22
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04046900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04046900, "Vaginal Microbiota Transplant". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT04046900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*